a new way to develop genetic treatments
a new way to develop genetic treatments
Currently, there are over 10,000 rare genetic diseases and growing. Most of these diseases are too rare to develop therapies for, under our current healthcare system. It has been said that it will be over 1000 years to make medicines for all these diseases if we keep approaching it the same way. But we think this is a solvable business model problem and that personalized medicine is on the horizon. We are changing the way we develop treatments with a more efficient, scalable drug development model, in order to reach more patients with rare diseases than ever before.
By utilizing Ai and RNA technology to create a scalable automated platform approach. We are creating an affordable way of getting rare diseases to the market quickly and sustainably.
Do you or one of your family member have a rare genetic disorder with no treatment? Be a part of the movement to eradicate these destructive diseases by becoming part of our other two partners, To Cure A Rose Foundation and Everlum Bio.
We are currently in the pre clinical and discovery phase for multiple pediatric diseases. We are in the development phase for an Antisense Oligonucleotide targeting a mutation of the HNRNPH2 Gene.
We're building the future. If you want help with your disease, we utilize To Cure A Rose Foundation and our rare lab Everlum Bio to help you put a team together to create and fast track a one of a kind therapy for you, your company, or your family member. Once it's developed, Chrysalis can help take it all the way.
We are currently offering an investment that will revolutionize healthcare. If you want your money to save lives, help change the world, and also see a quality return, please contact us!
Please send us a message for more information or an appointment.
Monday - Friday: 8:00am - 5:00pm
Saturday - Sunday: Closed
Chrysalis Genetics
Copyright © 2024 Chrysalis Genetics - All Rights Reserved.